Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Etanercept in Kawasaki Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Seattle Children's Hospital
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Michael Portman, Seattle Children's Hospital
ClinicalTrials.gov Identifier:
NCT00841789
First received: February 10, 2009
Last updated: September 15, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
No publications provided by Seattle Children's Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):